论文部分内容阅读
目的:探讨低分子肝素钙联合尿激酶治疗紫癜性肾病的效果观察。方法:将32例紫癜性肾病患儿随机分成对照组与治疗组,治疗组在对照组治疗的基础上加用低分子肝素钙及尿激酶治疗。结果:两组疗效比较,差异有统计学意义(2χ=5.926 7,P<0.05)。结论:低分子肝素钙联合尿激酶治疗紫癜性肾病疗效安全满意。
Objective: To investigate the effect of low molecular weight heparin combined with urokinase in the treatment of purpuric nephropathy. Methods: Thirty-two children with purpuric nephropathy were randomly divided into control group and treatment group. The treatment group was treated with low molecular weight heparin and urokinase on the basis of the control group. Results: There was significant difference between the two groups (2χ = 5.926 7, P <0.05). Conclusion: Low molecular weight heparin combined with urokinase in the treatment of purpuric nephropathy is safe and satisfactory.